Table 3 Antibiotic resistance profiles of major bacterial pathogens isolated in patients’ samples
From: Animal source food eating habits of outpatients with antimicrobial resistance in Bukavu, D.R. Congo
Antibiotic | n (%) | EC (%) | EB (%) | ECp (%) | KP (%) | MS (%) | SA (%) | SP (%) | SM (%) |
|---|---|---|---|---|---|---|---|---|---|
Fluoroquinolones | |||||||||
CIP | 90 (14.7) | 41.9 | 50 | 81.8 | 61.5 | 66.7 | 26.7 | 0 | 100 |
NOR | 35 (5.7) | 61.5 | NT | 100 | 0 | NT | 100 | 100 | 66.7 |
Aminoglycosides | |||||||||
GEN | 64 (10.5) | 58.3 | 57.1 | 100 | 62.5 | 100 | 28.6 | 0 | 0 |
AMK | 39 (6.4) | 30 | 0 | 0 | 11.1 | 0 | 50 | 0 | 0 |
Cephalosporins | |||||||||
CRO_CTX | 56 (9.2) | 73.1 | 100 | 100 | 72.7 | 100 | 33.3 | 100 | 100 |
CAZ | 31 (5.1) | 100 | 100 | 100 | 100 | 100 | NT | 100 | 100 |
CXM | 29 (4.7) | 100 | NT | NT | 0 | NT | 0 | NT | NT |
Carbapenems | |||||||||
IPM | 39 (6.4) | 0 | NT | 20 | 0 | NT | 0 | NT | 0 |
MEM | 25 (4.1) | 0 | 0 | 83.3 | 0 | 0 | NT | 0 | 0 |
Tetracyclines | |||||||||
TET | 23 (3.8) | 33.3 | NT | 50 | NT | NT | 60 | NT | 100 |
DOX | 16 (2.6) | 50 | 100 | NT | 0 | NT | 0 | NT | NT |
Penicillin | |||||||||
Augmentin | 19 (3.1) | 100 | 100 | 100 | 100 | 100 | NT | NT | 100 |
OXA | 13 (2.1) | 100 | NT | NT | 100 | NT | 83.3 | NT | NT |
PIP | 12 (2.0) | 100 | NT | NT | 100 | 100 | NT | NT | NT |
Macrolides | |||||||||
CLR | 18 (2.9) | 62.5 | 75 | NT | NT | NT | 16.7 | NT | NT |
ERY | 14 (2.3) | 100 | 100 | NT | 0 | NT | 0 | NT | NT |
Others (lincosamides, chloramphenicol and glycopeptides) | |||||||||
CLI | 37 (6.1) | 78.9 | 33.3 | NT | 100 | NT | 27.3 | NT | NT |
CHL | 34 (5.6) | 33.3 | 100 | 100 | 81.8 | 100 | 0 | NT | 100 |
VAN | 16 (2.6) | 100 | NT | 14.3 | NT | NT | NT | NT | NT |